A 4-week multicentre randomized double-blind double-dummy parallel group ambulatory blood pressure monitoring study to investigate whether treatment with lumiracoxib 100 mg once daily results in an improved 24-hour blood pressure profile compared to ibuprofen 600 mg three times a day in osteoarthritis patients with controlled hypertension.

Next Previous
Trial Profile

A 4-week multicentre randomized double-blind double-dummy parallel group ambulatory blood pressure monitoring study to investigate whether treatment with lumiracoxib 100 mg once daily results in an improved 24-hour blood pressure profile compared to ibuprofen 600 mg three times a day in osteoarthritis patients with controlled hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Feb 2017

At a glance

  • Drugs Lumiracoxib (Primary) ; Ibuprofen
  • Indications Hypertension; Musculoskeletal pain; Osteoarthritis
  • Focus Pharmacodynamics; Therapeutic Use

    • Most Recent Events

    • 13 Jul 2007 Status changed from in progress to completed.
    • 13 Jul 2007 Results have been reported.
    • 01 Dec 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top